Loading…
Sotera Health Company is projected to rise to $18.81 by 2027, a +21% move from its current price of $15.54. SHC is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $15.33 | $15.54 | $15.76 | +0.01% |
| May 30 | $15.24 | $15.54 | $15.85 | +0.03% |
| May 31 | $15.17 | $15.55 | $15.93 | +0.04% |
| Jun 1 | $15.12 | $15.55 | $15.99 | +0.05% |
| Jun 2 | $15.07 | $15.55 | $16.04 | +0.06% |
| Jun 3 | $15.03 | $15.55 | $16.09 | +0.08% |
| Jun 4 | $14.99 | $15.55 | $16.14 | +0.09% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $14.99 | $15.55 | $16.14 | +0.09% |
| Week 2 | $14.77 | $15.57 | $16.41 | +0.18% |
| Week 3 | $14.61 | $15.58 | $16.61 | +0.27% |
| Week 4 | $14.48 | $15.60 | $16.80 | +0.36% |
| Week 5 | $14.37 | $15.61 | $16.96 | +0.45% |
| Week 6 | $14.27 | $15.62 | $17.11 | +0.54% |
| Week 7 | $14.18 | $15.64 | $17.25 | +0.63% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets.
The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries.
The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
Sotera Health Company trades at $15.66 and has a market cap of $4.47B. It ranks 1420.
The current price sits near a defined technical backdrop with a 30-day range that provides context for near-term moves. The 2026 forecast shows a neutral outlook with a min of $13.13, an avg of $15.66, and a max of $20.76.
Beyond 2026, the forecast turns bullish, with rising averages through 2030 and beyond: 2027 avg $19.01, 2028 avg $18.94, 2029 avg $20.29, 2030 avg $22.77, 2031 avg $23.95, 2032 avg $28.72, 2033 avg $32.02, 2034 avg $32.20, 2035 avg $34.35, 2040 avg $49.89, and 2050 avg $91.98. The implied upside ranges from a 0% ROI in 2026 to 487.4% by 2050, with sentiment shifting to bullish in the later years.
A major floor 15.5% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.0% away) — a key level to hold.
The nearest ceiling, 4.9% above — a clean break opens room to run.
A major ceiling 23.4% above — clearing it would confirm fresh momentum.
Key SHC support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SHC market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $15.68 | Sell | $15.64 | Sell |
| MA 10 | $15.52 | Buy | $15.60 | Sell |
| MA 20 | $15.54 | Buy | $15.55 | Sell |
| MA 50 | $15.13 | Buy | $15.53 | Buy |
| MA 100 | $16.19 | Sell | $15.72 | Sell |
| MA 200 | $16.25 | Sell | $15.55 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 50.49 | Neutral |
| Stoch RSI (14) | 35.69 | Neutral |
| CCI (20) | 0.45 | Neutral |
| Williams %R (14) | -57.53 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | -1.52 | Sell |
| Bollinger %B (20,2) | 0.50 | Neutral |
| Stochastic %K (14) | 42.47 | Neutral |
| TRIX (15) | 0.07 | Buy |
| Awesome (5,34) | 0.06 | Buy |
| Ultimate (7,14,28) | 53.54 | Neutral |
| Momentum (10) | -0.09 | Sell |
| Aroon Osc (25) | -80.00 | Sell |
| Hull MA (9) | 15.84 | Sell |
| ADX (14) | 9.86 | Neutral |
| ATR (14) | 0.21 | Info |
30-day technical picture: sentiment is NEUTRAL with an RSI14 of 50. The short-term moving averages show SMA50 at $15.04 and SMA200 at $16.22. Key near-term support sits at $15.23 and resistance at $16.30. The thirty-day price range spans from $14.36 to $17.08.
The stock exhibits an annualized volatility of 30%, reflecting notable variability within the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $13.13 | $15.54 | $20.45 | 0% | Neutral | |
| $15.36 | $18.81 | $24.10 | +21% | Bullish | |
| $14.98 | $18.68 | $24.56 | +20% | Bullish | |
| $15.65 | $19.80 | $26.58 | +27% | Bullish | |
| $17.35 | $22.25 | $30.39 | +43% | Bullish | |
| $17.99 | $23.35 | $32.39 | +50% | Bullish | |
| $21.17 | $27.78 | $39.08 | +79% | Bullish | |
| $23.41 | $31.04 | $44.22 | +100% | Bullish | |
| $23.38 | $31.31 | $45.13 | +101% | Bullish | |
| $24.54 | $33.16 | $48.34 | +113% | Bullish | |
| $34.15 | $48.14 | $73.50 | +210% | Bullish | |
| $57.69 | $87.20 | $142.68 | +461% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $13.13 | $15.54 | $18.24 | +0.00% |
| June 2026 | $13.63 | $15.89 | $18.90 | +2.28% |
| July 2026 | $13.40 | $15.72 | $18.87 | -1.08% |
| August 2026 | $13.30 | $15.68 | $18.96 | -0.27% |
| September 2026 | $13.66 | $16.16 | $19.66 | +3.08% |
| October 2026 | $13.85 | $16.44 | $20.11 | +1.72% |
| November 2026 | $13.71 | $16.33 | $20.06 | -0.70% |
| December 2026 | $13.88 | $16.57 | $20.45 | +1.48% |
Click any year to see its month-by-month SHC forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect SHC to range from $13.13 to $20.45 through 2026. The $15.54 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The SHC price prediction for 2027 points to an average of $18.81 (low $15.36, high $24.10) — a potential gain of +21% on today's $15.54. Momentum favours further upside here.
In 2028, SHC is projected to trade between $14.98 and $24.56, averaging $18.68 — a potential gain of +20% from today's $15.54. That is -1% versus the projected 2027 average. Buyers look set to stay in control over this stretch.
Sotera Health Company's 2029 outlook centres on $19.80, within a $15.65 to $26.58 range. That is up +6% on the projected 2028 average. That marks a +27% change versus current levels. Momentum favours further upside here.
By 2030, SHC could reach as high as $30.39, with a base case around $22.25 and support toward $17.35 — roughly +43% from $15.54. Buyers look set to stay in control over this stretch.
Expect SHC to range from $17.99 to $32.39 through 2031. The $23.35 average target implies a +50% move from current prices. That is up +5% on the projected 2030 average. Momentum favours further upside here.
The SHC price prediction for 2032 points to an average of $27.78 (low $21.17, high $39.08) — a potential gain of +79% on today's $15.54. Buyers look set to stay in control over this stretch.
In 2033, SHC is projected to trade between $23.41 and $44.22, averaging $31.04 — a potential gain of +100% from today's $15.54. That is up +12% on the projected 2032 average. Momentum favours further upside here.
Sotera Health Company's 2034 outlook centres on $31.31, within a $23.38 to $45.13 range. That is up +1% on the projected 2033 average. That marks a +101% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, SHC could reach as high as $48.34, with a base case around $33.16 and support toward $24.54 — roughly +113% from $15.54. Momentum favours further upside here.
Expect SHC to range from $34.15 to $73.50 through 2040. The $48.14 average target implies a +210% move from current prices. That is up +45% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The SHC price prediction for 2050 points to an average of $87.20 (low $57.69, high $142.68) — a potential gain of +461% on today's $15.54. Momentum favours further upside here.
Investing $1,000 in SHC today (≈ 64.350064 SHC) could be worth
$5,611.31
+$4,611.31 (+461%) by 2050 · US Dollar
Based on the average projected SHC price of $87.2 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SHCwould be worth at today's price.
$1,000 invested in SHC on May 27, 2025 (≈ 80.450521 SHC) would be worth
$1,250.2
+$250.2 (+25.0%) today · 1.25× · US Dollar
Based on a SHC entry price of $12.43 vs. today's $15.54.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $15.55 | $999.36 | -0.1% |
| 1 month ago | $15.81 | $982.92 | -1.7% |
| 3 months ago | $16.47 | $943.53 | -5.6% |
| 6 months ago | $17.48 | $889.02 | -11.1% |
| 1 year ago | $12.43 | $1,250.2 | +25.0% |
| All time (5.0y) ago | $24.3 | $639.51 | -36.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SHC forecast.
Our base-case forecast reaches $31.00 around 2033.
Implied market cap at $31.00: $8.84B
The multi-year forecast paints a bullish path, with rising averages and substantial upside through the 2030s and beyond. By 2030, the avg is $22.77 with a 45.4% ROI, suggesting meaningful upside from the current level. The trajectory continues to 2031 ($23.95, 52.9%), 2032 ($28.72, 83.4%), 2033 ($32.02, 104.5%), 2034 ($32.20, 105.6%), and 2035 ($34.35, 119.3%).
Looking further out, 2040 shows an avg of $49.89 with a 218.6% ROI and 2050 an avg of $91.98 with a 487.4% ROI, both indicating substantial long-run upside. The max forecasts reach as high as $31.11 in 2030, $76.19 in 2040, and $150.52 in 2050, with the 2050 sentiment remaining BULLISH. These figures are estimates and not guarantees, and actual results depend on future conditions.
Tap a question to reveal the answer.
The 2030 forecast shows an avg price of $22.77 with a max of $31.11 and a min of $17.76, and a projected ROI of 45.4% with a BULLISH sentiment.
The forecast includes a bullish outlook from 2027 onward with rising averages (e.g., 2027 avg $19.01, 2030 avg $22.77, 2040 avg $49.89, 2050 avg $91.98) and positive ROIs in later years, but these are estimates and not guarantees.
Yes. The 2035 max forecast is $50.07, with an avg of $34.35 and a bullish sentiment.
Current price is $15.66 and market cap is $4.47B.
The 2040 forecast shows an avg of $49.89 with a max of $76.19, a min of $35.39, and a ROI of 218.6%, with sentiment BULLISH.
Sotera Health Company Community Discussion
0Share your Sotera Health Company price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.